1,046 filings
Page 7 of 53
4
David Scott Jones
22 Jun 23
EyePoint Pharmaceuticals / David Scott Jones ownership change
9:16am
4
Dario A. Paggiarino
22 Jun 23
EyePoint Pharmaceuticals / Dario A. Paggiarino ownership change
9:15am
4
George Elston
22 Jun 23
EyePoint Pharmaceuticals / George Elston ownership change
9:15am
4
Nancy Lurker
22 Jun 23
EyePoint Pharmaceuticals / Nancy Lurker ownership change
9:14am
4
Jay S. Duker
22 Jun 23
EyePoint Pharmaceuticals / Jay S. Duker ownership change
9:13am
8-K
EYPT
EyePoint Pharmaceuticals Inc
21 Jun 23
Departure of Directors or Certain Officers
7:53am
8-K
EYPT
EyePoint Pharmaceuticals Inc
5 Jun 23
EyePoint Pharmaceuticals Completes Enrollment in Phase 2 PAVIA Clinical Trial of EYP-1901 in Non-Proliferative Diabetic Retinopathy
7:06am
4
EYPT
EyePoint Pharmaceuticals Inc
31 May 23
EyePoint Pharmaceuticals / Ye Liu ownership change
5:22pm
4
Michael Craig Pine
30 May 23
EyePoint Pharmaceuticals / Michael Craig Pine ownership change
5:14pm
4
George Elston
30 May 23
EyePoint Pharmaceuticals / George Elston ownership change
5:13pm
144/A
EYPT
EyePoint Pharmaceuticals Inc
26 May 23
Notice of proposed sale of securities (amended)
10:34am
144/A
Therapeutics OcuMension
26 May 23
Notice of proposed sale of securities (amended)
9:57am
144
Therapeutics OcuMension
26 May 23
Notice of proposed sale of securities
7:00am
8-K/A
EYPT
EyePoint Pharmaceuticals Inc
23 May 23
Financial Statements and Exhibits
5:24pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
18 May 23
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties
7:06am
4
Nancy Lurker
15 May 23
EyePoint Pharmaceuticals / Nancy Lurker ownership change
6:15pm
10-Q
2023 Q1
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
4 May 23
2:41pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
3 May 23
EyePoint Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
SC 13G/A
Cormorant Global Healthcare Master Fund, LP
1 May 23
EyePoint Pharmaceuticals / Cormorant Global Healthcare Master Fund ownership change
4:23pm
DEFA14A
EYPT
EyePoint Pharmaceuticals Inc
28 Apr 23
Additional proxy soliciting materials
4:02pm